Blanket Purchase Agreement V797P5261B-VA797BP0466

The Department of Veterans Affairs (VA) National Acquisition Center has awarded a single-award Blanket Purchase Agreement (BPA) to Anip Acquisition Co, doing business as Ani Pharmaceuticals, for the acquisition of corticotropin. This $595,337.50 BPA has a period of performance through June 1, 2024, and was established under Ani Pharmaceuticals' existing Federal Supply Schedule (FSS) contract with the VA for "DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS." Additionally,...

This Blanket Purchase Agreement was awarded by the Department of Veterans Affairs National Acquisition Center to Ani Pharmaceuticals, Inc. for the procurement of corticotropin gel. The single award BPA was established against the Pharmaceuticals and Drugs GSA schedule and carries a potential value of $120,425.60. Delivery orders may be placed under this BPA through July 14, 2022 to acquire corticotropin gel for use by the Department of Veterans Affairs in treating various medical conditions. The...

The Department of Veterans Affairs (VA) National Acquisition Center awarded an Indefinite Delivery Contract to Golden State Medical Supply, Inc. to provide Betamethasone Dipropionate 0.05% Cream in 15g and 45g sizes to the VA, Department of Defense (DoD), Bureau of Prisons, and Indian Health Service. This single-award contract has a ceiling value of $2,807,485.34 and a period of performance from February 1, 2025 to January 31, 2026, with four one-year option periods. Golden State Medical Supply,...

The Department of Health and Human Services' Indian Health Service (IHS) has awarded a Blanket Purchase Agreement (BPA) to Rare Disease Therapeutics, Inc., a woman-owned small business, to supply ANASCORP scorpion antivenom injections and related pharmaceutical products to IHS clinics and hospitals primarily serving tribal communities in Arizona, Nevada, and Utah. The BPA, which is structured as a single-award Indefinite Delivery Vehicle (IDV) under the company's GSA Schedule contract for...

The U.S. Department of Veterans Affairs (VA) awarded Recordati Rare Diseases Inc., a foreign-owned pharmaceutical manufacturer, a $15.6 million multiple-award Federal Supply Schedule (FSS-61-IB) contract and a $3.1 million single-award Blanket Purchase Agreement to supply specialized orphan drugs and rare disease treatments. The contract vehicles allow the VA to efficiently procure Recordati's portfolio of medications, including Signifor LAR, Carbaglu, Cystadane, Isturisa, and Cystadrops,...

The U.S. Department of Veterans Affairs (VA) National Acquisition Center awarded a $1.388 million single-award Indefinite Delivery Contract (IDC) to Specgx LLC, doing business as Mallinckrodt Pharmaceuticals, for the supply of Atropine Sulfate/Diphenoxylate Hydrochloride tablets. The contract has a base period of one year from May 27, 2023 to May 26, 2024, with four one-year option periods, for a total potential performance period of 5 years. This IDC allows the VA, Department of Defense, Bureau...

The Department of Veterans Affairs National Acquisition Center awarded Rare Disease Therapeutics, Inc. a $250,000 Blanket Purchase Agreement (BPA) to provide the VA with access to the company's catalog of specialty pharmaceutical products, particularly orphan drugs for rare diseases. This single-award IDV leverages Rare Disease Therapeutics' GSA Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB), allowing efficient procurement of these specialized medications. The Indian Health...

The federal contract IDV awarded to Specgx LLC, doing business as Mallinckrodt Pharmaceuticals, is a single-award Indefinite Delivery Contract with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $4,154,058.30 over five years, establishes Specgx LLC as the national supply source for Methylphenidate HCL Extended-Release Tablets in 10mg and 20mg strengths for the Department of Defense, Bureau of Prisons, Indian Health Service, and Department of Veterans Affairs....

This indefinite delivery contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Amgen USA Inc. for the provision of Calcitonin Gene-Related Peptide (CGRP) agents. The single-award contract has a ceiling value of $100,527,333.60 and a period of performance from February 26, 2025, to February 25, 2026, with four one-year option periods. The contract aims to provide an uninterrupted source of supply for CGRP products to the VA, including its...

The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $13.8 million single-award indefinite delivery/indefinite quantity (IDIQ) contract to American Regent Inc., a pharmaceutical manufacturer and distributor, to provide various pharmaceuticals to support military medical treatment facilities worldwide. The contract, which runs through September 2031, enables American Regent to deliver critical injectable medications, including atropine sulfate, glycopyrrolate, and...